Posts tagged with: "Avandia" Results 261 - 280 of 887
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Oct 2010, 5:34 am by Ed Wallis
” Doctors in the US “prescribing Avandia will have to justify the decision. [read post]
28 Oct 2010, 5:32 am by Ed Wallis
” Doctors in the US “prescribing Avandia will have to justify the decision. [read post]
28 Apr 2010, 2:34 pm by Carey, Danis & Lowe
The FDA's decision to consider ending the current Avandia study because of the heart attack risk, along with the Saudia Arabian FDA's suspension of Avandia, suggests that everyone is convinced of Avandia's risks -- but GlaxoSmithKline simply won't acknowledge them until it's forced to. [read post]
21 Jul 2010, 7:22 am by Carey, Danis & Lowe
It's unclear why the FDA wants to keep Avandia on the market, but it’s clear why GlaxoSmithKline, Avandia's maker, might be interested in doing so. [read post]
3 Jun 2010, 7:17 am by John J. Cord
We’ve reported a lot on Avandia this year. [read post]
13 Jun 2010, 9:46 am by Dr. Shezad Malik
The agency is already scheduled next month to evaluate the Avandia's safety. [read post]
19 Nov 2007, 9:15 pm
Regarding the Finance Committee Investigation of Avandia, November 15, 2007: "We place a... [read post]
20 Oct 2010, 7:28 am by Mark Zamora
Studies that show Avandia may increase the risk of heart failure illustrate a case of when a drug does the opposite of what it’s supposed to. [read post]
24 May 2007, 8:51 am
Avandia's warning label already warned of the risk of cardiovascular adverse events. [read post]
24 Feb 2010, 8:13 pm
" For several years now, the FDA has been working to determine (1) whether Avandia should remain on the market; and (2) whether Avandia causes heart attacks. [read post]
8 Jun 2007, 1:20 am
One of the ads they showed was for Avandia, I think. [read post]
23 Feb 2010, 12:46 am by Dr. Shezad Malik
The FDA has scheduled a meeting of outside advisers in July to discuss Avandia. [read post]
20 Aug 2010, 1:40 pm by Mark Zamora
From the NYT:  Federal drug regulators ordered GlaxoSmithKline to send a letter to crucial doctors describing a hearing in July where an expert advisory panel discussed the risks of Avandia, the company’s controversial diabetes medicine.Doctors who received the letter, dated July 28, are investigators in a study called the Tide trial, which was intended to compare the heart risks of Avandia with those of Actos, a similar drug made by Takeda … [read post]
29 Jun 2009, 10:00 pm
We'll try to keep it mercifully brief.In In re Avandia Marketing, Sales Practices and Prods. [read post]